Global DNA Repair Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Publisher Name :
Date: 04-Oct-2022
No. of pages: 112

The DNA Repair Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global DNA Repair Drugs market size is estimated to be worth US$ 610.8 million in 2021 and is forecast to a readjusted size of USD 1901.1 million by 2028 with a CAGR of 17.6% during review period. Oncological accounting for % of the DNA Repair Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PARP Inhibitors segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of DNA Repair Drugs include 4SC AG, ARCAGY/ GINECO GROUP, Bristol Myers Squibb, British Columbia Cancer Agency, and Cambridge University Hospitals NHS Foundation Trust, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market Segmentation

DNA Repair Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- PARP Inhibitors

- Other

Market segment by Application can be divided into

- Oncological

- Stroke

The key market players for global DNA Repair Drugs market are listed below:

- 4SC AG

- ARCAGY/ GINECO GROUP

- Bristol Myers Squibb

- British Columbia Cancer Agency

- Cambridge University Hospitals NHS Foundation Trust

- Genentech

- Georgetown University

- German Breast Group

- GlaxoSmithKline

- Jiangsu Hengrui Medicine

- Johnson & Johnson

- Jonsson Comprehensive Cancer Center

- Karyopharm Therapeutics

- KuDOS Pharmaceuticals

- National Health Service

- National Institutes of Health

- Tesaro

Market segment by region, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

- South America (Brazil, Argentina, Colombia, and Rest of South America)

- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe DNA Repair Drugs product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of DNA Repair Drugs, with price, sales, revenue and global market share of DNA Repair Drugs from 2019 to 2022.

Chapter 3, the DNA Repair Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the DNA Repair Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and DNA Repair Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of DNA Repair Drugs.

Chapter 13, 14, and 15, to describe DNA Repair Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Global DNA Repair Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Table of Contents

1 Market Overview
1.1 DNA Repair Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global DNA Repair Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 PARP Inhibitors
1.2.3 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global DNA Repair Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncological
1.3.3 Stroke
1.4 Global DNA Repair Drugs Market Size & Forecast
1.4.1 Global DNA Repair Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global DNA Repair Drugs Sales in Volume (2017-2028)
1.4.3 Global DNA Repair Drugs Price (2017-2028)
1.5 Global DNA Repair Drugs Production Capacity Analysis
1.5.1 Global DNA Repair Drugs Total Production Capacity (2017-2028)
1.5.2 Global DNA Repair Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 DNA Repair Drugs Market Drivers
1.6.2 DNA Repair Drugs Market Restraints
1.6.3 DNA Repair Drugs Trends Analysis
2 Manufacturers Profiles
2.1 4SC AG
2.1.1 4SC AG Details
2.1.2 4SC AG Major Business
2.1.3 4SC AG DNA Repair Drugs Product and Services
2.1.4 4SC AG DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 ARCAGY/ GINECO GROUP
2.2.1 ARCAGY/ GINECO GROUP Details
2.2.2 ARCAGY/ GINECO GROUP Major Business
2.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Product and Services
2.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bristol Myers Squibb
2.3.1 Bristol Myers Squibb Details
2.3.2 Bristol Myers Squibb Major Business
2.3.3 Bristol Myers Squibb DNA Repair Drugs Product and Services
2.3.4 Bristol Myers Squibb DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 British Columbia Cancer Agency
2.4.1 British Columbia Cancer Agency Details
2.4.2 British Columbia Cancer Agency Major Business
2.4.3 British Columbia Cancer Agency DNA Repair Drugs Product and Services
2.4.4 British Columbia Cancer Agency DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Cambridge University Hospitals NHS Foundation Trust
2.5.1 Cambridge University Hospitals NHS Foundation Trust Details
2.5.2 Cambridge University Hospitals NHS Foundation Trust Major Business
2.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product and Services
2.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Genentech
2.6.1 Genentech Details
2.6.2 Genentech Major Business
2.6.3 Genentech DNA Repair Drugs Product and Services
2.6.4 Genentech DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Georgetown University
2.7.1 Georgetown University Details
2.7.2 Georgetown University Major Business
2.7.3 Georgetown University DNA Repair Drugs Product and Services
2.7.4 Georgetown University DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 German Breast Group
2.8.1 German Breast Group Details
2.8.2 German Breast Group Major Business
2.8.3 German Breast Group DNA Repair Drugs Product and Services
2.8.4 German Breast Group DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business
2.9.3 GlaxoSmithKline DNA Repair Drugs Product and Services
2.9.4 GlaxoSmithKline DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Jiangsu Hengrui Medicine
2.10.1 Jiangsu Hengrui Medicine Details
2.10.2 Jiangsu Hengrui Medicine Major Business
2.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Product and Services
2.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business
2.11.3 Johnson & Johnson DNA Repair Drugs Product and Services
2.11.4 Johnson & Johnson DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Jonsson Comprehensive Cancer Center
2.12.1 Jonsson Comprehensive Cancer Center Details
2.12.2 Jonsson Comprehensive Cancer Center Major Business
2.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product and Services
2.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Karyopharm Therapeutics
2.13.1 Karyopharm Therapeutics Details
2.13.2 Karyopharm Therapeutics Major Business
2.13.3 Karyopharm Therapeutics DNA Repair Drugs Product and Services
2.13.4 Karyopharm Therapeutics DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 KuDOS Pharmaceuticals
2.14.1 KuDOS Pharmaceuticals Details
2.14.2 KuDOS Pharmaceuticals Major Business
2.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Product and Services
2.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 National Health Service
2.15.1 National Health Service Details
2.15.2 National Health Service Major Business
2.15.3 National Health Service DNA Repair Drugs Product and Services
2.15.4 National Health Service DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 National Institutes of Health
2.16.1 National Institutes of Health Details
2.16.2 National Institutes of Health Major Business
2.16.3 National Institutes of Health DNA Repair Drugs Product and Services
2.16.4 National Institutes of Health DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Tesaro
2.17.1 Tesaro Details
2.17.2 Tesaro Major Business
2.17.3 Tesaro DNA Repair Drugs Product and Services
2.17.4 Tesaro DNA Repair Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 DNA Repair Drugs Breakdown Data by Manufacturer
3.1 Global DNA Repair Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global DNA Repair Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in DNA Repair Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 DNA Repair Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 DNA Repair Drugs Manufacturer Market Share in 2021
3.5 Global DNA Repair Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and DNA Repair Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global DNA Repair Drugs Market Size by Region
4.1.1 Global DNA Repair Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global DNA Repair Drugs Revenue by Region (2017-2028)
4.2 North America DNA Repair Drugs Revenue (2017-2028)
4.3 Europe DNA Repair Drugs Revenue (2017-2028)
4.4 Asia-Pacific DNA Repair Drugs Revenue (2017-2028)
4.5 South America DNA Repair Drugs Revenue (2017-2028)
4.6 Middle East and Africa DNA Repair Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global DNA Repair Drugs Sales in Volume by Type (2017-2028)
5.2 Global DNA Repair Drugs Revenue by Type (2017-2028)
5.3 Global DNA Repair Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global DNA Repair Drugs Sales in Volume by Application (2017-2028)
6.2 Global DNA Repair Drugs Revenue by Application (2017-2028)
6.3 Global DNA Repair Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America DNA Repair Drugs Sales by Type (2017-2028)
7.2 North America DNA Repair Drugs Sales by Application (2017-2028)
7.3 North America DNA Repair Drugs Market Size by Country
7.3.1 North America DNA Repair Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America DNA Repair Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe DNA Repair Drugs Sales by Type (2017-2028)
8.2 Europe DNA Repair Drugs Sales by Application (2017-2028)
8.3 Europe DNA Repair Drugs Market Size by Country
8.3.1 Europe DNA Repair Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe DNA Repair Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific DNA Repair Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific DNA Repair Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific DNA Repair Drugs Market Size by Region
9.3.1 Asia-Pacific DNA Repair Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific DNA Repair Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America DNA Repair Drugs Sales by Type (2017-2028)
10.2 South America DNA Repair Drugs Sales by Application (2017-2028)
10.3 South America DNA Repair Drugs Market Size by Country
10.3.1 South America DNA Repair Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America DNA Repair Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa DNA Repair Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa DNA Repair Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa DNA Repair Drugs Market Size by Country
11.3.1 Middle East & Africa DNA Repair Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa DNA Repair Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of DNA Repair Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of DNA Repair Drugs
12.3 DNA Repair Drugs Production Process
12.4 DNA Repair Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 DNA Repair Drugs Typical Distributors
13.3 DNA Repair Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global DNA Repair Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global DNA Repair Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. 4SC AG Basic Information, Manufacturing Base and Competitors
Table 4. 4SC AG Major Business
Table 5. 4SC AG DNA Repair Drugs Product and Services
Table 6. 4SC AG DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. ARCAGY/ GINECO GROUP Basic Information, Manufacturing Base and Competitors
Table 8. ARCAGY/ GINECO GROUP Major Business
Table 9. ARCAGY/ GINECO GROUP DNA Repair Drugs Product and Services
Table 10. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 12. Bristol Myers Squibb Major Business
Table 13. Bristol Myers Squibb DNA Repair Drugs Product and Services
Table 14. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. British Columbia Cancer Agency Basic Information, Manufacturing Base and Competitors
Table 16. British Columbia Cancer Agency Major Business
Table 17. British Columbia Cancer Agency DNA Repair Drugs Product and Services
Table 18. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Cambridge University Hospitals NHS Foundation Trust Basic Information, Manufacturing Base and Competitors
Table 20. Cambridge University Hospitals NHS Foundation Trust Major Business
Table 21. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product and Services
Table 22. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Genentech Basic Information, Manufacturing Base and Competitors
Table 24. Genentech Major Business
Table 25. Genentech DNA Repair Drugs Product and Services
Table 26. Genentech DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Georgetown University Basic Information, Manufacturing Base and Competitors
Table 28. Georgetown University Major Business
Table 29. Georgetown University DNA Repair Drugs Product and Services
Table 30. Georgetown University DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. German Breast Group Basic Information, Manufacturing Base and Competitors
Table 32. German Breast Group Major Business
Table 33. German Breast Group DNA Repair Drugs Product and Services
Table 34. German Breast Group DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 36. GlaxoSmithKline Major Business
Table 37. GlaxoSmithKline DNA Repair Drugs Product and Services
Table 38. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 40. Jiangsu Hengrui Medicine Major Business
Table 41. Jiangsu Hengrui Medicine DNA Repair Drugs Product and Services
Table 42. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Major Business
Table 45. Johnson & Johnson DNA Repair Drugs Product and Services
Table 46. Johnson & Johnson DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Jonsson Comprehensive Cancer Center Basic Information, Manufacturing Base and Competitors
Table 48. Jonsson Comprehensive Cancer Center Major Business
Table 49. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product and Services
Table 50. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Karyopharm Therapeutics Basic Information, Manufacturing Base and Competitors
Table 52. Karyopharm Therapeutics Major Business
Table 53. Karyopharm Therapeutics DNA Repair Drugs Product and Services
Table 54. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. KuDOS Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. KuDOS Pharmaceuticals Major Business
Table 57. KuDOS Pharmaceuticals DNA Repair Drugs Product and Services
Table 58. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. National Health Service Basic Information, Manufacturing Base and Competitors
Table 60. National Health Service Major Business
Table 61. National Health Service DNA Repair Drugs Product and Services
Table 62. National Health Service DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. National Institutes of Health Basic Information, Manufacturing Base and Competitors
Table 64. National Institutes of Health Major Business
Table 65. National Institutes of Health DNA Repair Drugs Product and Services
Table 66. National Institutes of Health DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Tesaro Basic Information, Manufacturing Base and Competitors
Table 68. Tesaro Major Business
Table 69. Tesaro DNA Repair Drugs Product and Services
Table 70. Tesaro DNA Repair Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global DNA Repair Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 72. Global DNA Repair Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in DNA Repair Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global DNA Repair Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 75. Head Office and DNA Repair Drugs Production Site of Key Manufacturer
Table 76. DNA Repair Drugs New Entrant and Capacity Expansion Plans
Table 77. DNA Repair Drugs Mergers & Acquisitions in the Past Five Years
Table 78. Global DNA Repair Drugs Sales by Region (2017-2022) & (K Units)
Table 79. Global DNA Repair Drugs Sales by Region (2023-2028) & (K Units)
Table 80. Global DNA Repair Drugs Revenue by Region (2017-2022) & (USD Million)
Table 81. Global DNA Repair Drugs Revenue by Region (2023-2028) & (USD Million)
Table 82. Global DNA Repair Drugs Sales by Type (2017-2022) & (K Units)
Table 83. Global DNA Repair Drugs Sales by Type (2023-2028) & (K Units)
Table 84. Global DNA Repair Drugs Revenue by Type (2017-2022) & (USD Million)
Table 85. Global DNA Repair Drugs Revenue by Type (2023-2028) & (USD Million)
Table 86. Global DNA Repair Drugs Price by Type (2017-2022) & (USD/Unit)
Table 87. Global DNA Repair Drugs Price by Type (2023-2028) & (USD/Unit)
Table 88. Global DNA Repair Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Global DNA Repair Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Global DNA Repair Drugs Revenue by Application (2017-2022) & (USD Million)
Table 91. Global DNA Repair Drugs Revenue by Application (2023-2028) & (USD Million)
Table 92. Global DNA Repair Drugs Price by Application (2017-2022) & (USD/Unit)
Table 93. Global DNA Repair Drugs Price by Application (2023-2028) & (USD/Unit)
Table 94. North America DNA Repair Drugs Sales by Country (2017-2022) & (K Units)
Table 95. North America DNA Repair Drugs Sales by Country (2023-2028) & (K Units)
Table 96. North America DNA Repair Drugs Revenue by Country (2017-2022) & (USD Million)
Table 97. North America DNA Repair Drugs Revenue by Country (2023-2028) & (USD Million)
Table 98. North America DNA Repair Drugs Sales by Type (2017-2022) & (K Units)
Table 99. North America DNA Repair Drugs Sales by Type (2023-2028) & (K Units)
Table 100. North America DNA Repair Drugs Sales by Application (2017-2022) & (K Units)
Table 101. North America DNA Repair Drugs Sales by Application (2023-2028) & (K Units)
Table 102. Europe DNA Repair Drugs Sales by Country (2017-2022) & (K Units)
Table 103. Europe DNA Repair Drugs Sales by Country (2023-2028) & (K Units)
Table 104. Europe DNA Repair Drugs Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe DNA Repair Drugs Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe DNA Repair Drugs Sales by Type (2017-2022) & (K Units)
Table 107. Europe DNA Repair Drugs Sales by Type (2023-2028) & (K Units)
Table 108. Europe DNA Repair Drugs Sales by Application (2017-2022) & (K Units)
Table 109. Europe DNA Repair Drugs Sales by Application (2023-2028) & (K Units)
Table 110. Asia-Pacific DNA Repair Drugs Sales by Region (2017-2022) & (K Units)
Table 111. Asia-Pacific DNA Repair Drugs Sales by Region (2023-2028) & (K Units)
Table 112. Asia-Pacific DNA Repair Drugs Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific DNA Repair Drugs Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific DNA Repair Drugs Sales by Type (2017-2022) & (K Units)
Table 115. Asia-Pacific DNA Repair Drugs Sales by Type (2023-2028) & (K Units)
Table 116. Asia-Pacific DNA Repair Drugs Sales by Application (2017-2022) & (K Units)
Table 117. Asia-Pacific DNA Repair Drugs Sales by Application (2023-2028) & (K Units)
Table 118. South America DNA Repair Drugs Sales by Country (2017-2022) & (K Units)
Table 119. South America DNA Repair Drugs Sales by Country (2023-2028) & (K Units)
Table 120. South America DNA Repair Drugs Revenue by Country (2017-2022) & (USD Million)
Table 121. South America DNA Repair Drugs Revenue by Country (2023-2028) & (USD Million)
Table 122. South America DNA Repair Drugs Sales by Type (2017-2022) & (K Units)
Table 123. South America DNA Repair Drugs Sales by Type (2023-2028) & (K Units)
Table 124. South America DNA Repair Drugs Sales by Application (2017-2022) & (K Units)
Table 125. South America DNA Repair Drugs Sales by Application (2023-2028) & (K Units)
Table 126. Middle East & Africa DNA Repair Drugs Sales by Region (2017-2022) & (K Units)
Table 127. Middle East & Africa DNA Repair Drugs Sales by Region (2023-2028) & (K Units)
Table 128. Middle East & Africa DNA Repair Drugs Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa DNA Repair Drugs Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa DNA Repair Drugs Sales by Type (2017-2022) & (K Units)
Table 131. Middle East & Africa DNA Repair Drugs Sales by Type (2023-2028) & (K Units)
Table 132. Middle East & Africa DNA Repair Drugs Sales by Application (2017-2022) & (K Units)
Table 133. Middle East & Africa DNA Repair Drugs Sales by Application (2023-2028) & (K Units)
Table 134. DNA Repair Drugs Raw Material
Table 135. Key Manufacturers of DNA Repair Drugs Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. DNA Repair Drugs Typical Distributors
Table 139. DNA Repair Drugs Typical Customers
List of Figures
Figure 1. DNA Repair Drugs Picture
Figure 2. Global DNA Repair Drugs Revenue Market Share by Type in 2021
Figure 3. PARP Inhibitors
Figure 4. Other
Figure 5. Global DNA Repair Drugs Revenue Market Share by Application in 2021
Figure 6. Oncological
Figure 7. Stroke
Figure 8. Global DNA Repair Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global DNA Repair Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global DNA Repair Drugs Sales (2017-2028) & (K Units)
Figure 11. Global DNA Repair Drugs Price (2017-2028) & (USD/Unit)
Figure 12. Global DNA Repair Drugs Production Capacity (2017-2028) & (K Units)
Figure 13. Global DNA Repair Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. DNA Repair Drugs Market Drivers
Figure 15. DNA Repair Drugs Market Restraints
Figure 16. DNA Repair Drugs Market Trends
Figure 17. Global DNA Repair Drugs Sales Market Share by Manufacturer in 2021
Figure 18. Global DNA Repair Drugs Revenue Market Share by Manufacturer in 2021
Figure 19. DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 DNA Repair Drugs Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 DNA Repair Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Global DNA Repair Drugs Sales Market Share by Region (2017-2028)
Figure 23. Global DNA Repair Drugs Revenue Market Share by Region (2017-2028)
Figure 24. North America DNA Repair Drugs Revenue (2017-2028) & (USD Million)
Figure 25. Europe DNA Repair Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific DNA Repair Drugs Revenue (2017-2028) & (USD Million)
Figure 27. South America DNA Repair Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa DNA Repair Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Global DNA Repair Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global DNA Repair Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global DNA Repair Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global DNA Repair Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global DNA Repair Drugs Revenue Market Share by Application (2017-2028)
Figure 34. Global DNA Repair Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America DNA Repair Drugs Sales Market Share by Type (2017-2028)
Figure 36. North America DNA Repair Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America DNA Repair Drugs Sales Market Share by Country (2017-2028)
Figure 38. North America DNA Repair Drugs Revenue Market Share by Country (2017-2028)
Figure 39. United States DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe DNA Repair Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe DNA Repair Drugs Sales Market Share by Application (2017-2028)
Figure 44. Europe DNA Repair Drugs Sales Market Share by Country (2017-2028)
Figure 45. Europe DNA Repair Drugs Revenue Market Share by Country (2017-2028)
Figure 46. Germany DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific DNA Repair Drugs Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific DNA Repair Drugs Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific DNA Repair Drugs Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific DNA Repair Drugs Revenue Market Share by Region (2017-2028)
Figure 55. China DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America DNA Repair Drugs Sales Market Share by Type (2017-2028)
Figure 62. South America DNA Repair Drugs Sales Market Share by Application (2017-2028)
Figure 63. South America DNA Repair Drugs Sales Market Share by Country (2017-2028)
Figure 64. South America DNA Repair Drugs Revenue Market Share by Country (2017-2028)
Figure 65. Brazil DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa DNA Repair Drugs Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa DNA Repair Drugs Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa DNA Repair Drugs Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa DNA Repair Drugs Revenue Market Share by Region (2017-2028)
Figure 71. Turkey DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa DNA Repair Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of DNA Repair Drugs in 2021
Figure 76. Manufacturing Process Analysis of DNA Repair Drugs
Figure 77. DNA Repair Drugs Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs